Healthcare News

Pharming announces preliminary, unaudited revenue and select financial information for Q3 2026 & full results brought forward to October 27, 2026.

Continued strong VYVGART performance drives $1.7 billion in global product net sales, representing 54% year-over-year growth and 13% quarter-over-quarter growth sBLA for VYVGART Hytrulo in IMNM on...

Year-to-date total sales growth of 24.6% at CER1, or 23.0% as reported, with the core portfolio2 achieving sales growth of 24.2%1 Further upgraded FY 2026 financial guidance: total sales growth around...

Croissance du chiffre d’affaires du Groupe de 24,6 % à taux de change constant1 (TCC) au cours des neuf premiers mois de l’année 2026 ou 23,0 % en données publiées, avec une croissance du portefeuille...

Ad hoc announcement pursuant to Art. 53 LRBasel, 22 October 2026 Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group...

Ad-hoc-Mitteilung gemäss Art. 53 KRBasel, 22. Oktober 2026 Roche setzt starke Dynamik im dritten Quartal mit Umsatzwachstum von +7% zu konstanten Wechselkursen (CER) und +8% in CHF fort;...

明尼阿波利斯, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Egg Medical 今日宣布，其关于 EggNest 增强型辐射防护设备 (ERPD) 的前瞻性研究成果，已成功发表于《美国心脏协会期刊》(JAHA)。这项真实世界临床研究于俄亥俄州辛辛那提市 The Christ Hospital...

明尼阿波利斯, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Egg Medical 今日宣布，其 EggNest 增強型輻射防護裝置 (ERPD) 的前瞻研究已在《美國心臟協會期刊》(JAHA) 刊登。這項於俄亥俄州辛辛那提 The Christ Hospital 進行的真實世界臨床研究證明，輻射防護足以讓介入實驗室人員安全施行手術，無須穿著沉重的個人防護鉛圍裙。 ...

MINNEAPOLIS, 22 oct. 2026 (GLOBE NEWSWIRE) -- Egg Medical a annoncé aujourd’hui la publication d’une étude prospective dans le Journal of the American Heart Association (JAHA), évaluant ses...

MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Egg Medical gab heute die Veröffentlichung einer prospektiven Studie im Journal of the American Heart Association (JAHA) bekannt, in der die...